Exploration of Asthma & Allergy

Characteristics	eCRS	neCRS	Total
Sex	Male	34	5	39
Female	40	4	44
Age	61.8 ± 13.9	62 ± 16.26	61.8 ± 14.1
Asthma	53	4	57
Mean blood eosinophils percentage	6%	3%	5%
CT (ethmoid ≥ maxillary)	73	1	74

Declarations

Author contributions

SDDJ, BVdOM, and PNF: Data curation, Writing—original draft. FCdC, KCdMC, and ESO: Data curation. JEF and SORV: Writing—original draft.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This research has been submitted and approved by Comitê de Ética em Pesquisa do Hospital Universitário Clementino Fraga Filho (HUCFF-UFRJ), number 090/09. The study was conducted in accordance with the Declaration of Helsinki.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

All datasets for this study are included in the manuscript.

Funding

Not applicable.

Copyright

References

Avdeeva K, Fokkens W. Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2018;18:25. [DOI] [PubMed] [PMC]

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464. [DOI] [PubMed]

Garcia JFB, Giavina-Bianchi P. Efficacy and safety of dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis. Arq Asma Alerg Imunol. 2021;5:232–6. Portuguese.

Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy. 2015;70:995–1003. [DOI] [PubMed] [PMC]

Workman AD, Kohanski MA, Cohen NA. Biomarkers in chronic rhinosinusitis with nasal polyps. Immunol Allergy Clin North Am. 2018;38:679–92. [DOI] [PubMed] [PMC]

Baiardini I, Paoletti G, Mariani A, Malvezzi L, Pirola F, Spriano G, et al. Nasal polyposis quality of life (NPQ): development and validation of the first specific quality of life questionnaire for chronic rhinosinusitis with nasal polyps. Healthcare (Basel). 2022;10:253. [DOI] [PubMed] [PMC]

Rosati D, Rosato C, Pagliuca G, Cerbelli B, Della Rocca C, Di Cristofano C, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2020;41:102286. [DOI] [PubMed]

Kim JY, Han YE, Seo Y, Choe G, Kim MK, Huh G, et al. Revisiting the clinical scoring system for the prognosis of chronic rhinosinusitis with nasal polyps. Yonsei Med J. 2019;60:578–84. [DOI] [PubMed] [PMC]

Kim DK, Kang SI, Kong IG, Cho YH, Song SK, Hyun SJ, et al. Two-track medical treatment strategy according to the clinical scoring system for chronic rhinosinusitis. Allergy Asthma Immunol Res. 2018;10:490–502. [DOI] [PubMed] [PMC]

10.

Nakayama T, Sugimoto N, Okada N, Tsurumoto T, Mitsuyoshi R, Takaishi S, et al. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps. Auris Nasus Larynx. 2019;46:374–83. [DOI] [PubMed]

11.

Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120:162–6. [DOI] [PubMed]

12.

Fujieda S, Imoto Y, Kato Y, Ninomiya T, Tokunaga T, Tsutsumiuchi T, et al. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68:403–12. [DOI] [PubMed]